Does metastatic colorectal cancer in elderly patients have specific features: the final results of a prospective phase II study of bevacizumab in combination with capecitabine as first-line treatment?

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Prospective Phase ◽

S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis

British Journal of Cancer ◽

10.1038/bjc.2013.479 ◽

2013 ◽

Vol 109 (6) ◽

pp. 1420-1427 ◽

Cited By ~ 16

Author(s):

S Y Kim ◽

Y S Hong ◽

E K Shim ◽

S-Y Kong ◽

A Shin ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Prospective Phase ◽

Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e3283417f3e ◽

2011 ◽

Vol 22 (2) ◽

pp. 191-197 ◽

Cited By ~ 15

Author(s):

Eduard Vrdoljak ◽

Tomislav Omrčen ◽

Marijo Boban ◽

Andina Hrabar

Keyword(s):

Colorectal Cancer ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0681-2 ◽

2008 ◽

Vol 62 (6) ◽

pp. 931-936 ◽

Cited By ~ 23

Author(s):

Eric François ◽

Jean-François Berdah ◽

Emmanuel Chamorey ◽

Gérard Lesbats ◽

Eric Teissier ◽

...

Keyword(s):

Colorectal Cancer ◽

Elderly Patients ◽

Folinic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

BMC Cancer ◽

10.1186/1471-2407-10-567 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 33

Author(s):

Gemma Bruera ◽

Alessandra Santomaggio ◽

Katia Cannita ◽

Paola Lanfiuti Baldi ◽

Marianna Tudini ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G

Annals of Oncology ◽

10.1093/annonc/mdy281.151 ◽

2018 ◽

Vol 29 ◽

pp. viii201

Author(s):

Y. Kito ◽

T. Yamada ◽

T. Matsumoto ◽

H. Yasui ◽

K. Murata ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6603493 ◽

2007 ◽

Vol 96 (3) ◽

pp. 439-444 ◽

Cited By ~ 21

Author(s):

E Bajetta ◽

◽

M Di Bartolomeo ◽

R Buzzoni ◽

L Mariani ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Colorectal Cancer Patients ◽

A phase II study of biweekly irinotecan (CPT-11) and 5-fluorouracil (5-FU) as first line treatment in advanced or metastatic colorectal cancer (CRC)

European Journal of Cancer ◽

10.1016/s0959-8049(01)81582-3 ◽

2001 ◽

Vol 37 ◽

pp. S295-S296 ◽

Cited By ~ 1

Author(s):

J. Salvador ◽

R. Bernabe ◽

M. Bolaños ◽

P. Borrega ◽

M. Valladares ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

British Journal of Cancer ◽

10.1038/sj.bjc.6602913 ◽

2005 ◽

Vol 94 (1) ◽

pp. 69-73 ◽

Cited By ~ 12

Author(s):

J Bennouna ◽

H Perrier ◽

B Paillot ◽

F Priou ◽

J H Jacob ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

FOLFOXIRI (irinotecan, oxaliplatin, and infusional 5FU/LV) in combination with bevacizumab (BV) in the first-line treatment of metastatic colorectal cancer (mCRC): A phase II study by the G.O.N.O. group

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4031 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4031-4031 ◽

Cited By ~ 12

Author(s):

A. Falcone ◽

G. Masi ◽

F. Loupakis ◽

E. Vasile ◽

A. Ciarlo ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive Tumor Therapy (TTD).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e14524 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e14524-e14524

Author(s):

Alfredo Carrato ◽

Bartolomeu Massuti Sureda ◽

Manuel Benavides ◽

Carmen Guillén Ponce ◽

Esther Falco ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Tumor Therapy ◽

Single Agent ◽

Cooperative Group ◽

Line Treatment ◽

First Line ◽